|
Feb 15
|
With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns
|
|
Feb 15
|
President of Enanta Pharmaceuticals Picks Up 5.9% More Stock
|
|
Feb 14
|
Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade
|
|
Feb 10
|
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
|
|
Feb 10
|
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
|
|
Feb 10
|
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024
|